Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jubilant Therapeutics Inc.

Clinical trials sponsored by Jubilant Therapeutics Inc., explained in plain language.

Now part of Jubilant Pharmova Limited JUBLPHARMA NSE

Biopharmaceutical company developing small molecule therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

New pill shows promise for rare blood cancers in early trial

Disease control Recruiting now

This study tests a new daily pill called JBI-802 in people with certain blood cancers (myeloproliferative neoplasms and MDS/MPN) who have too many platelets. The trial has two phases: first, finding a safe dose in about 30 adults, then checking if it works. Participants take the …

Phase: PHASE1, PHASE2 • Sponsor: Jubilant Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC